Cargando…

Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines

In the treatment of breast cancer, combination chemotherapy is used to overcome drug resistance. Combining doxorubicin and vinorelbine in the treatment of patients with metastatic breast cancer has shown high response rates; even single-agent vinorelbine in patients previously exposed to anthracycli...

Descripción completa

Detalles Bibliográficos
Autores principales: Liem, A A, Appleyard, M V C L, O'Neill, M A, Hupp, T R, Chamberlain, M P, Thompson, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747573/
https://www.ncbi.nlm.nih.gov/pubmed/12698197
http://dx.doi.org/10.1038/sj.bjc.6600898